Post Reply
1-2 of 2
that is super good news, too bad, I didn't include those "external reasons" into my stock selection, too bad, miss the boat ....
SINGAPORE, May 23 (Reuters) - Heart stent producer Biosensors International said on Wednesday it had been granted a U.S. patent for its Biolimus A9 drug.